Compare Amphastar Pharmaceuticals Inc (AMPH) vs United Parcel Service Inc (UPS) Price & Performance

AMPH trades at $18.72, down 1.58% with bearish technical signals despite oversold RSI readings. The company reported mixed Q1 2026 results with EPS of $0.42 missing estimates of $0.70, continuing a trend of recent earnings disappointments. Valuation metrics appear reasonable with P/E of 11.29 and P/B of 1.07, while profitability remains solid with 47.34% gross margins. Recent news includes a Zacks Strong Sell rating and ongoing securities law investigation.

The stock faces near-term headwinds from earnings misses and negative analyst sentiment, though current valuations provide some downside protection. Upside potential exists if the company can execute its strategic pivot to proprietary drugs and biosimilars while managing BAQSIMI discount pressures. Key risks include ongoing legal scrutiny and competitive pressures in the generic drug market.

UPS trades at $112.47, up 1.56% today, with a bullish technical signal and consistent earnings beats. The stock shows strong profitability with a 33.41% ROE and 5.94% net margin, though revenue has declined from $100.3B in 2022 to $88.66B in 2025. Recent news highlights a $48M investment in healthcare logistics and competition concerns from Amazon's logistics expansion.

Outlook is mixed: valuation appears reasonable with a P/E of 18.2, and analysts give a $112 consensus target, but revenue pressure and competitive threats pose risks. The dividend remains supported by solid cash flow, but growth depends on successful execution in a challenging environment.